Renal function and proteinuria after successful immunosuppressive therapies in patients with FSGS.

@article{Hogg2013RenalFA,
  title={Renal function and proteinuria after successful immunosuppressive therapies in patients with FSGS.},
  author={Ronald J. Hogg and Aaron M Friedman and Tom Greene and Milena K. Radeva and Milos N Budisavljevic and Jennifer Youngblut Gassman and Debbie S. Gipson and Jonathan Ashley Jefferson and Eunice G. John and Frederick J. Kaskel and Asha Moudgil and Marva M. Moxey-Mims and Luis Alfonso Ortiz and Jeffrey R. Schelling and William Schnaper and Tarak Srivastava and Howard A. Trachtman and V. Matti Vehaskari and Craig Wong and Robert P Woronieki and Scott K. Van Why and Anna Zolotnitskaya},
  journal={Clinical journal of the American Society of Nephrology : CJASN},
  year={2013},
  volume={8 2},
  pages={211-8}
}
BACKGROUND AND OBJECTIVES In the FSGS Clinical Trial, 22 cyclosporine-treated and 20 mycophenolate/dexamethasone-treated patients experienced a complete or partial remission after 26 weeks, completed 52 weeks of treatment, and were studied through 78 weeks. Herein, changes in the urine protein/creatinine ratio (UP/C) and estimated GFR (eGFR) throughout the entire study period are defined. DESIGN, SETTING, PARTICIPANTS, AND MEASUREMENTS The FSGS Clinical Trial, which was conducted from… CONTINUE READING
5 Citations
18 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 18 references

Similar Papers

Loading similar papers…